F16.2

Clinical Causes: Repeated use of hallucinogenic substances leading to brain adaptations Genetic predisposition influencing vulnerability to substance dependence Psychological factors such as chronic stress or mental health disorders Environmental factors including peer influence and exposure in social settings History of substance abuse or previous dependence issues

Key Symptoms: Strong cravings for hallucinogenic drugs Persistent desire or unsuccessful attempts to cut down or control use Tolerance, requiring increased amounts to achieve effects Withdrawal symptoms such as anxiety, irritability, or depression when not using the substance Preoccupation with obtaining and using hallucinogens Neglect of responsibilities at work, school, or home Continuing use despite physical or psychological problems caused or worsened by the substance Altered perceptions and hallucinations when not under the influence, particularly in withdrawal states

Diagnosis Path: Diagnosis involves a comprehensive clinical assessment, including patient history, psychiatric evaluation, and observation of abstinence symptoms. Healthcare professionals may use standardized tools to evaluate the severity of dependence and distinguish it from other mental health conditions. Confirming diagnosis typically requires evidence of compulsive use, tolerance, and withdrawal symptoms related to hallucinogenic drugs.

Treatment Protocols: Detoxification to manage withdrawal symptoms safely, often under medical supervision Psychotherapy such as cognitive-behavioral therapy (CBT) to address underlying psychological issues and develop coping strategies Support groups and peer support programs fostering a community of recovery Medication-assisted treatment may be considered to manage specific withdrawal symptoms or co-occurring mental health conditions Relapse prevention planning and ongoing outpatient care